2013-06-01
The untapped potential of Gallium 68-PET: The next wave of 68Ga-agents
Publication
Publication
Applied Radiation and Isotopes , Volume 76 p. 14- 23
68Gallium-PET (68Ga-PET) agents have significant clinical promise. The radionuclide can be produced from a 68Ge/68Ga generator on site and is a convenient alternative to cyclotron-based PET isotopes. The short half-life of 68Ga permits imaging applications with sufficient radioactivity while maintaining patient dose to an acceptable level. Furthermore, due to superior resolution, 68Ga-PET agents have the ability to replace current SPECT agents in many applications. This article outlines the upcoming agents and challenges faced during the translational development of 68Ga agents.
Additional Metadata | |
---|---|
, , | |
doi.org/10.1016/j.apradiso.2012.10.014, hdl.handle.net/1765/60642 | |
Applied Radiation and Isotopes | |
Organisation | Department of Nuclear Medicine |
Smith, D., Breeman, W., & Sims-Mourtada, J. (2013). The untapped potential of Gallium 68-PET: The next wave of 68Ga-agents. Applied Radiation and Isotopes, 76, 14–23. doi:10.1016/j.apradiso.2012.10.014 |